Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782581 · ClinicalTrials.gov registry record · NA
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
A NA study of Neoplasm, sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 1
- Study location
NCT06782581 is a NA study of Neoplasm that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 186 participants, roughly in line with the 185-participant average among 11 other Neoplasm trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06782581, a NA study of Neoplasm, is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to increase a sense of autonomy, competence, and connectedness, each of which have been shown to be associated with psychological benefits according to self-determination theory.
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Contribution to Caregivers Well-Being
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2024-08-06 |
| Est. Completion | 2027-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06782581
The ClinicalTrials.gov registry entry for NCT06782581 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 185-participant average among 11 other Neoplasm trials with a reported enrollment target. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT06782581 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06782581 about?
NCT06782581 is a clinical study titled "CARE Study: Cancer, Asian Americans, and Relationship Enrichment". The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to increase a sense of autonomy, competence, and connectedness, each of which ...
What is the current status of trial NCT06782581?
This trial is currently recruiting. It is a NA study. The enrollment target is 186 participants. The study started on 2024-08-06. Estimated completion is 2027-02-15.
What conditions does trial NCT06782581 study?
This clinical trial studies the following conditions: Neoplasm.
What interventions are being tested in trial NCT06782581?
The interventions under investigation include: Control (BEHAVIORAL), Contribution to Caregivers Well-Being (BEHAVIORAL).
Who is sponsoring clinical trial NCT06782581?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782581 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
RECRUITING · NA
-
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
RECRUITING · Phase 1
-
A Study of LY2835219 in Participants With Cancer
COMPLETED · Phase 1
-
Study of Karenitecin (BNP1350) to Treat Malignant Melanoma
COMPLETED · Phase 2
-
Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer
COMPLETED · Phase 1
-
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.